Back to Archived Journals » Research and Reports in Biochemistry » Volume 2

Modeling the alternative oxidase from the human pathogen Blastocystis using automated hybrid structural template assembly

Authors Standley D , van der Giezen M

Received 4 October 2011

Accepted for publication 25 October 2011

Published 12 January 2012 Volume 2012:2 Pages 1—8


Review by Single anonymous peer review

Peer reviewer comments 3

Video abstract presented by Daron Standley and Mark van der Giezen

Views: 1099

Daron M Standley1, Mark van der Giezen2
1Laboratory of Systems Immunology, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan; 2Centre for Eukaryotic Evolutionary Microbiology, Biosciences, College of Life and Environmental Sciences, University of Exeter, Exeter, UK

Abstract: Alternative oxidases (AOX) of human parasites represent attractive drug targets due to their absence in humans. However, the lack of a structure has prevented structure-based drug design. Moreover, a large helical insertion proves difficult for automated structural modeling efforts. We have used a novel hybrid structural modeling approach to generate a model that is globally consistent with a previous model but based on a phylogenetically closer template and systematic sampling of known fragments in the helical insertion. Our model, in agreement with site-directed mutagenesis studies, clearly assigns E200 as the iron-ligating residue as opposed to the previously suggested E201. Crystallization of AOX from another species has recently been reported suggesting that our blind prediction can be independently validated in the near future.

Keywords: homology modeling, protein structure, blind prediction, fragment assembly, active site, parasite, mitosome, hydrogenosome, evolution

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.